Shenzhen YHLO Biotech Co., Ltd.
SHH: 688575.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Yongbo Song
- Employees
- 1,759
- Headquarters
- Shenzhen, China
- IPO year
- 2021
- Market cap
- CN¥7.6B
- Website
- https://www.szyhlo.com
Loading 688575…
Loading profile data…Frequently asked questions about 688575
What does Shenzhen YHLO Biotech Co., Ltd. (688575.SS) do?
Shenzhen YHLO Biotech Co., Ltd. engages in developing, manufacturing, and distributing in-vitro diagnostic instruments and reagents in China. It offers clinical solutions for autoimmune, reproductive health, infectious, and other diseases; CLIA test panels, chemiluminescence immunoassay analyzers, and integration systems for immunoassay; ELISA t...
Where does 688575.SS trade?
Shenzhen YHLO Biotech Co., Ltd. (688575.SS) trades on the Shanghai Stock Exchange.
What sector is 688575.SS in?
Shenzhen YHLO Biotech Co., Ltd. (688575.SS) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Shenzhen YHLO Biotech Co., Ltd.?
Yongbo Song is the chief executive officer of Shenzhen YHLO Biotech Co., Ltd. (688575.SS).
Where is Shenzhen YHLO Biotech Co., Ltd. headquartered?
Shenzhen YHLO Biotech Co., Ltd. is headquartered in China.
Does 688575.SS pay a dividend?
Yes — Shenzhen YHLO Biotech Co., Ltd. (688575.SS) paid a trailing twelve-month dividend of CNY 0.21 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688575.SS go public?
Shenzhen YHLO Biotech Co., Ltd. (688575.SS) completed its initial public offering in 2021.